Association of decreased prefrontal hemodynamic response during a verbal fluency task with EGR3 gene polymorphism in patients with schizophrenia and in healthy individuals

NeuroImage

Volumn 85, Issue , 2014, Pages 527-534

  Nishimura, Yukika ^a   Takizawa, Ryu ^a,b   Koike, Shinsuke ^a,c   Kinoshita, Akihide ^a   Satomura, Yoshihiro ^a   Kawasaki, Shingo ^a,d   Yamasue, Hidenori ^a   Tochigi, Mamoru ^a   Kakiuchi, Chihiro ^a   Sasaki, Tsukasa ^c   Iwayama, Yoshimi ^e   Yamada, Kazuo ^e   Yoshikawa, Takeo ^e   Kasai, Kiyoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TOKYO   (Japan)

^d HITACHI LTD   (Japan)

^e RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Early growth response 3 (EGR3); Imaging genetics; Near infrared spectroscopy (NIRS); Prefrontal function; Schizophrenia; Verbal fluency task (VFT)

Indexed keywords

CHLORPROMAZINE; DIAZEPAM; EARLY GROWTH RESPONSE FACTOR 3; OXYHEMOGLOBIN;

ADULT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLOBAL ASSESSMENT OF FUNCTIONING; HEMODYNAMICS; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NEAR INFRARED SPECTROSCOPY; POSITIVE AND NEGATIVE SYNDROME SCALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOMATOLOGY; TASK PERFORMANCE; TRANSCRIPTION REGULATION; TREATMENT DURATION; VERBAL COMMUNICATION; VERBAL FLUENCY TASK;

DEOXYGENATED HEMOGLOBIN CONCENTRATION; DEOXYHB; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, 4TH EDITION, TEXT REVISION; DIFFUSION TENSOR IMAGING; DLPFC; DORSOLATERAL PREFRONTAL CORTEX; DSM-IV-TR; DTI; DUP; DURATION OF UNTREATED PSYCHOSIS; EARLY GROWTH RESPONSE; EARLY GROWTH RESPONSE 3 (EGR3); EGR; GAF; GLOBAL ASSESSMENT OF FUNCTIONING; HB; HC; HEALTHY CONTROL; HEMOGLOBIN; IMAGING GENETICS; JAPANESE VERSION OF THE NATIONAL ADULT READING TEST; JART; NEAR-INFRARED SPECTROSCOPY; NEAR-INFRARED SPECTROSCOPY (NIRS); NIRS; OXYGENATED HEMOGLOBIN CONCENTRATION; OXYHB; PANSS; POSITIVE AND NEGATIVE SYMPTOM SCALE; PREFRONTAL FUNCTION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; SZ; VERBAL FLUENCY TASK; VERBAL FLUENCY TASK (VFT); VFT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CEREBROVASCULAR CIRCULATION; DNA; EARLY GROWTH RESPONSE PROTEIN 3; FALSE POSITIVE REACTIONS; FEMALE; FUNCTIONAL NEUROIMAGING; HEMODYNAMICS; HEMOGLOBINS; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SPECTROSCOPY, NEAR-INFRARED; VERBAL BEHAVIOR;

EID: 84889671758     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.08.021     Document Type: Article

References (80)

1. Allen P., Luigjes J., Howes O.D., Egerton A., Hirao K., Valli I., Kambeitz J., Fusar-Poli P., Broome M., McGuire P. Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals. Schizophr. Bull. 2012, 38:1268-1276.
2. APA Diagnostic and Statistical Manual of Mental Disorders 2000, 4th ed.
3. Beckmann A.M., Wilce P.A. Egr transcription factors in the nervous system. Neurochem. Int. 1997, 31:477-510. (discussion 517-476).
4. Bilbo S.D., Schwarz J.M. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front. Behav. Neurosci. 2009, 3:14.
5. Broome M.R., Matthiasson P., Fusar-Poli P., Woolley J.B., Johns L.C., Tabraham P., Bramon E., Valmaggia L., Williams S.C., Brammer M.J., Chitnis X., McGuire P.K. Neural correlates of executive function and working memory in the 'at-risk mental state'. Br. J. Psychiatry 2009, 194:25-33.
6. Buckley P.F., Pillai A., Howell K.R. Brain-derived neurotrophic factor: findings in schizophrenia. Curr. Opin. Psychiatry 2011, 24:122-127.
7. Callicott J.H., Mattay V.S., Verchinski B.A., Marenco S., Egan M.F., Weinberger D.R. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am. J. Psychiatry 2003, 160:2209-2215.
8. Cheng M.C., Liao D.L., Hsiung C.A., Chen C.Y., Liao Y.C., Chen C.H. Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex. Int. J. Neuropsychopharmacol. 2008, 11:207-216.
9. Cheung V., Chiu C.P., Law C.W., Cheung C., Hui C.L., Chan K.K., Sham P.C., Deng M.Y., Tai K.S., Khong P.L., McAlonan G.M., Chua S.E., Chen E. Positive symptoms and white matter microstructure in never-medicated first episode schizophrenia. Psychol. Med. 2011, 41:1709-1719.
10. Collier D.A., Li T. The genetics of schizophrenia: glutamate not dopamine?. Eur. J. Pharmacol. 2003, 480:177-184.
11. Cui X., Bray S., Bryant D.M., Glover G.H., Reiss A.L. A quantitative comparison of NIRS and fMRI across multiple cognitive tasks. NeuroImage 2011, 54:2808-2021.
12. Curtis V.A., Bullmore E.T., Brammer M.J., Wright I.C., Williams S.C., Morris R.G., Sharma T.S., Murray R.M., McGuire P.K. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am. J. Psychiatry 1998, 155:1056-1063.
13. Delpy D.T., Cope M., van der Zee P., Arridge S., Wray S., Wyatt J. Estimation of optical pathlength through tissue from direct time of flight measurement. Phys. Med. Biol. 1988, 33:1433-1442.
14. Drager B., Jansen A., Bruchmann S., Forster A.F., Pleger B., Zwitserlood P., Knecht S. How does the brain accommodate to increased task difficulty in word finding? A functional MRI study. Neuroimage 2004, 23:1152-1160.
15. Drexhage R.C., van der Heul-Nieuwenhuijsen L., Padmos R.C., van Beveren N., Cohen D., Versnel M.A., Nolen W.A., Drexhage H.A. Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int. J. Neuropsychopharmacol. 2010, 13:1369-1381.
16. Eldredge L.C., Gao X.M., Quach D.H., Li L., Han X., Lomasney J., Tourtellotte W.G. Abnormal sympathetic nervous system development and physiological dysautonomia in Egr3-deficient mice. Development 2008, 135:2949-2957.
17. Gallitano-Mendel A., Izumi Y., Tokuda K., Zorumski C.F., Howell M.P., Muglia L.J., Wozniak D.F., Milbrandt J. The immediate early gene early growth response gene 3 mediates adaptation to stress and novelty. Neuroscience 2007, 148:633-643.
18. Gallitano-Mendel A., Wozniak D.F., Pehek E.A., Milbrandt J. Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects. Neuropsychopharmacology 2008, 33:1266-1275.
19. Gerber D.J., Hall D., Miyakawa T., Demars S., Gogos J.A., Karayiorgou M., Tonegawa S. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8993-8998.
20. Guo A.Y., Sun J., Jia P., Zhao Z. A novel microRNA and transcription factor mediated regulatory network in schizophrenia. BMC Syst. Biol. 2010, 4:10.
21. Haeussinger F.B., Heinzel S., Hahn T., Schecklmann M., Ehlis A.C., Fallgatter A.J. Simulation of near-infrared light absorption considering individual head and prefrontal cortex anatomy: implications for optical neuroimaging. PloS One 2011, 6:e26377.
22. Heinzel S., Haeussinger F.B., Hahn T., Ehlis A.C., Plichta M.M., Fallgatter A.J. Variability of (functional) hemodynamics as measured with simultaneous fNIRS and fMRI during intertemporal choice. NeuroImage 2013, 71:125-134.
23. Henry J.D., Crawford J.R. A meta-analytic review of verbal fluency performance in patients with traumatic brain injury. Neuropsychology 2004, 18:621-628.
24. Hildeman D.A., Mitchell T., Kappler J., Marrack P. T cell apoptosis and reactive oxygen species. J. Clin. Invest. 2003, 111:575-581.
25. Hoshi Y., Kobayashi N., Tamura M. Interpretation of near-infrared spectroscopy signals: a study with a newly developed perfused rat brain model. J. Appl. Physiol. 2001, 90:1657-1662.
26. Huppert T.J., Hoge R.D., Diamond S.G., Franceschini M.A., Boas D.A. A temporal comparison of BOLD, ASL, and NIRS hemodynamic responses to motor stimuli in adult humans. Neuroimage 2006, 29:368-382.
27. Kakimoto Y., Nishimura Y., Hara N., Okada M., Tanii H., Okazaki Y. Intrasubject reproducibility of prefrontal cortex activities during a verbal fluency task over two repeated sessions using multi-channel near-infrared spectroscopy. Psychiatry Clin. Neurosci. 2009, 63:491-499.
28. Kameyama M., Fukuda M., Uehara T., Mikuni M. Sex and age dependencies of cerebral blood volume changes during cognitive activation: a multichannel near-infrared spectroscopy study. Neuroimage 2004, 22:1715-1721.
29. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
30. Keshavan M.S., Tandon R., Boutros N.N., Nasrallah H.A. Schizophrenia, "just the facts": what we know in 2008. Part 3: neurobiology. Schizophr. Res. 2008, 106:89-107.
31. Kim S.H., Song J.Y., Joo E.J., Lee K.Y., Ahn Y.M., Kim Y.S. EGR3 as a potential susceptibility gene for schizophrenia in Korea. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:1355-1360.
32. Kim J.H., Roberts D.S., Hu Y., Lau G.C., Brooks-Kayal A.R., Farb D.H., Russek S.J. Brain-derived neurotrophic factor uses CREB and Egr3 to regulate NMDA receptor levels in cortical neurons. J. Neurochem. 2012, 120:210-219.
33. Kirilina E., Jelzow A., Heine A., Niessing M., Wabnitz H., Bruhl R., Ittermann B., Jacobs A.M., Tachtsidis I. The physiological origin of task-evoked systemic artefacts in functional near infrared spectroscopy. NeuroImage 2012, 61:70-81.
34. Koike S., Takizawa R., Nishimura Y., Takano Y., Takayanagi Y., Kinou M., Araki T., Harima H., Fukuda M., Okazaki Y., Kasai K. Different hemodynamic response patterns in the prefrontal cortical sub-regions according to the clinical stages of psychosis. Schizophr. Res. 2011, 132:54-61.
35. Krabbendam L., O'Daly O., Morley L.A., van Os J., Murray R.M., Shergill S.S. Using the Stroop task to investigate the neural correlates of symptom change in schizophrenia. Br. J. Psychiatry 2009, 194:373-374.
36. Kyogoku C., Yanagi M., Nishimura K., Sugiyama D., Morinobu A., Fukutake M., Maeda K., Shirakawa O., Kuno T., Kumagai S. Association of calcineurin A gamma subunit (PPP3CC) and early growth response 3 (EGR3) gene polymorphisms with susceptibility to schizophrenia in a Japanese population. Psychiatry Res. 2011, 185:16-19.
37. Lawrie S.M., Olabi B., Hall J., McIntosh A.M. Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?. World Psychiatry 2011, 10:19-31.
38. Li L., Yun S.H., Keblesh J., Trommer B.L., Xiong H., Radulovic J., Tourtellotte W.G. Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory. Mol. Cell. Neurosci. 2007, 35:76-88.
39. Liu B.C., Zhang J., Wang L., Li X.W., Wang Y., Ji J., Yang F.P., Wan C.L., Gao L.H., Xu Y.F., Feng G.Y., He L., Zhao X.Z., He G. No association between EGR gene family polymorphisms and schizophrenia in the Chinese population. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:506-509.
40. Maki A., Yamashita Y., Ito Y., Watanabe E., Mayanagi Y., Koizumi H. Spatial and temporal analysis of human motor activity using noninvasive NIR topography. Med. Phys. 1995, 22:1997-2005.
41. Matsuoka K., Uno M., Kasai K., Koyama K., Kim Y. Estimation of premorbid IQ in individuals with Alzheimer's disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test. Psychiatry Clin. Neurosci. 2006, 60:332-339.
42. McGuffin P., Owen M.J., Farmer A.E. Genetic basis of schizophrenia. Lancet 1995, 346:678-682.
43. Meyer-Lindenberg A. Imaging genetics of schizophrenia. Dialogues Clin. Neurosci. 2010, 12:449-456.
44. Miyakawa T., Leiter L.M., Gerber D.J., Gainetdinov R.R., Sotnikova T.D., Zeng H., Caron M.G., Tonegawa S. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8987-8992.
45. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:4270-4274.
46. Ning Q.L., Ma X.D., Jiao L.Z., Niu X.R., Li J.P., Wang B., Zhang H., Ma J. A family-based association study of the EGR3 gene polymorphisms and schizophrenia. Yi Chuan 2012, 34:307-314.
47. O'Donovan K.J., Tourtellotte W.G., Millbrandt J., Baraban J.M. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 1999, 22:167-173.
48. Okamoto M., Dan H., Sakamoto K., Takeo K., Shimizu K., Kohno S., Oda I., Isobe S., Suzuki T., Kohyama K., Dan I. Three-dimensional probabilistic anatomical cranio-cerebral correlation via the international 10-20 system oriented for transcranial functional brain mapping. Neuroimage 2004, 21:99-111.
49. Park H.G., Kim S.H., Kim H.S., Ahn Y.M., Kang U.G., Kim Y.S. Repeated electroconvulsive seizure treatment in rats reduces inducibility of early growth response genes and hyperactivity in response to cocaine administration. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1014-1021.
50. Poirier R., Cheval H., Mailhes C., Garel S., Charnay P., Davis S., Laroche S. Distinct functions of egr gene family members in cognitive processes. Front. Neurosci. 2008, 2:47-55.
51. Potkin S.G., Fleming K., Jin Y., Gulasekaram B. Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics. J. Clin. Psychopharmacol. 2001, 21:479-483.
52. Rapoport J.L., Giedd J.N., Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry 2012, 17:1228-1238.
53. Shattuck D.W., Mirza M., Adisetiyo V., Hojatkashani C., Salamon G., Narr K.L., Poldrack R.A., Bilder R.M., Toga A.W. Construction of a 3D probabilistic atlas of human cortical structures. Neuroimage 2008, 39:1064-1080.
54. Singh A.K., Dan I. Exploring the false discovery rate in multichannel NIRS. Neuroimage 2006, 33:542-549.
55. Singh A.K., Okamoto M., Dan H., Jurcak V., Dan I. Spatial registration of multichannel multi-subject fNIRS data to MNI space without MRI. Neuroimage 2005, 27:842-851.
56. Skelly L.R., Calhoun V., Meda S.A., Kim J., Mathalon D.H., Pearlson G.D. Diffusion tensor imaging in schizophrenia: relationship to symptoms. Schizophr. Res. 2008, 98:157-162.
57. Smee C., Krabbendam L., O'Daly O., Prins A.M., Nalesnik N., Morley L., Samson G., Shergill S. An fMRI study of prefrontal dysfunction and symptomatic recovery in schizophrenia. Acta Psychiatr. Scand. 2011, 123:440-450.
58. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71:877-892.
59. Stolp H.B. Neuropoietic cytokines in normal brain development and neurodevelopmental disorders. Mol. Cell. Neurosci. 2013, 53:63-68.
60. Strangman G., Culver J.P., Thompson J.H., Boas D.A. A quantitative comparison of simultaneous BOLD fMRI and NIRS recordings during functional brain activation. Neuroimage 2002, 17:719-731.
61. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60:1187-1192.
62. Suto T., Fukuda M., Ito M., Uehara T., Mikuni M. Multichannel near-infrared spectroscopy in depression and schizophrenia: cognitive brain activation study. Biol. Psychiatry 2004, 55:501-511.
63. Tabares-Seisdedos R., Rubenstein J.L. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Mol. Psychiatry 2009, 14:563-589.
64. Takahashi T., Takikawa Y., Kawagoe R., Shibuya S., Iwano T., Kitazawa S. Influence of skin blood flow on near-infrared spectroscopy signals measured on the forehead during a verbal fluency task. NeuroImage 2011, 57:991-1002.
65. Takizawa R., Kasai K., Kawakubo Y., Marumo K., Kawasaki S., Yamasue H., Fukuda M. Reduced frontopolar activation during verbal fluency task in schizophrenia: a multi-channel near-infrared spectroscopy study. Schizophr. Res. 2008, 99:250-262.
66. Takizawa R., Hashimoto K., Tochigi M., Kawakubo Y., Marumo K., Sasaki T., Fukuda M., Kasai K. Association between sigma-1 receptor gene polymorphism and prefrontal hemodynamic response induced by cognitive activation in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:491-498.
67. Takizawa R., Tochigi M., Kawakubo Y., Marumo K., Sasaki T., Fukuda M., Kasai K. Association between catechol-O-methyltransferase Val108/158Met genotype and prefrontal hemodynamic response in schizophrenia. PLoS One 2009, 4:e5495.
68. Tandon R., Keshavan M.S., Nasrallah H.A. Schizophrenia, "just the facts": what we know in 2008. 2. Epidemiology and etiology. Schizophr. Res. 2008, 102:1-18.
69. Tandon R., Keshavan M.S., Nasrallah H.A. Schizophrenia, "just the facts": what we know in 2008. Part 1: overview. Schizophr. Res. 2008, 100:4-19.
70. Tourtellotte W.G., Milbrandt J. Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nat. Genet. 1998, 20:87-91.
71. Tsuzuki D., Jurcak V., Singh A.K., Okamoto M., Watanabe E., Dan I. Virtual spatial registration of stand-alone fNIRS data to MNI space. Neuroimage 2007, 34:1506-1518.
72. Tupak S.V., Badewien M., Dresler T., Hahn T., Ernst L.H., Herrmann M.J., Fallgatter A.J., Ehlis A.C. Differential prefrontal and frontotemporal oxygenation patterns during phonemic and semantic verbal fluency. Neuropsychologia 2012, 50:1565-1569.
73. Verma V., Rasmussen K., Dawe G.S. Effects of short-term and chronic olanzapine treatment on immediate early gene protein and tyrosine hydroxylase immunoreactivity in the rat locus coeruleus and medial prefrontal cortex. Neuroscience 2006, 143:573-585.
74. Verma V., Lim E.P., Han S.P., Nagarajah R., Dawe G.S. Chronic high-dose haloperidol has qualitatively similar effects to risperidone and clozapine on immediate-early gene and tyrosine hydroxylase expression in the rat locus coeruleus but not medial prefrontal cortex. Neurosci. Res. 2007, 57:17-28.
75. Weigelt K., Carvalho L.A., Drexhage R.C., Wijkhuijs A., de Wit H., van Beveren N.J., Birkenhager T.K., Bergink V., Drexhage H.A. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors. Brain Behav. Immun. 2011, 25:1162-1169.
76. Wieland G.D., Nehmann N., Muller D., Eibel H., Siebenlist U., Suhnel J., Zipfel P.F., Skerka C. Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-kappaB p50 and p65. J. Cell Sci. 2005, 118:3203-3212.
77. Williams A.A., Ingram W.M., Levine S., Resnik J., Kamel C.M., Lish J.R., Elizalde D.I., Janowski S.A., Shoker J., Kozlenkov A., Gonzalez-Maeso J., Gallitano A.L. Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine. Neuropsychopharmacology 2012, 37:2285-2298.
78. Winder D.G., Sweatt J.D. Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat. Rev. Neurosci. 2001, 2:461-474.
79. Yamada K., Gerber D.J., Iwayama Y., Ohnishi T., Ohba H., Toyota T., Aruga J., Minabe Y., Tonegawa S., Yoshikawa T. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:2815-2820.
80. Zhang R., Lu S., Meng L., Min Z., Tian J., Valenzuela R.K., Guo T., Tian L., Zhao W., Ma J. Genetic evidence for the association between the early growth response 3 (EGR3) gene and schizophrenia. PLoS One 2012, 7:e30237.